Evidence map›Paper›PMID 35218000›Full record

ArticleClinical drug investigation2022

The Impact of COVID-19 Vaccination on the Italian Healthcare System: A Scenario Analysis.

Andrea Marcellusi, Gianluca Fabiano, Paolo Sciattella, Massimo Andreoni, Francesco Saverio Mennini

Abstract read
In one paragraph

Article in Clinical drug investigation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Neurovascular Adverse Effects of Sars-Cov-2 Vaccination.Drug design, development and therapy · 2024
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Narrative Review of the COVID-19 Pandemic's First Two Years in Italy.International journal of environmental research and public health · 2022
    Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Andrea MarcellusiEconomic Evaluation and HTA, Centre for Economic and International Studies (EEHTA-CEIS), Faculty of Economics, University of Tor Vergata, Rome, Italy. andrea.marcellusi@uniroma2.it.ORCID http://orcid.org/0000-0002-3974-3798
Gianluca FabianoInstitute for Leadership and Management in Health, Kingston University London, London, UK.
Paolo SciattellaEconomic Evaluation and HTA, Centre for Economic and International Studies (EEHTA-CEIS), Faculty of Economics, University of Tor Vergata, Rome, Italy.
Massimo AndreoniInfectious Diseases Clinic, Policlinic of Tor Vergata, Rome, Italy.
Francesco Saverio MenniniEconomic Evaluation and HTA, Centre for Economic and International Studies (EEHTA-CEIS), Faculty of Economics, University of Tor Vergata, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectiveDuring 2020, the only instruments for fighting against the pandemic peaks were lockdowns, physical distancing, closure of schools and non-essential businesses, and travel restrictions. The new vaccination strategy adopted in Italy in 2021 represented a new perspective for policymakers.

objectiveThe aim of this study was to estimate the effects of the national immunisation strategy for coronavirus disease 2019 (COVID-19) in Italy on the national healthcare system.

methodsAn epidemiological scenario analysis was developed in order to simulate the impact of the COVID-19 pandemic on the Italian national healthcare system in 2021. Hospitalisations, intensive care unit (ICU) admissions and death rates were modelled based on 2020 data. Costs were estimated using hospital admissions from the Policlinico of Tor Vergata Hospital in Rome. Two scenarios were tested, one with vaccination and the second without.

resultsThe roll-out of vaccinations to protect against COVID-19 was estimated to prevent 52,115 deaths in 2021, 45.2% less than what was expected in the absence of immunisation. Based on the assumptions underlying the two epidemiological scenarios, our model predicted an overall reduction of 2.4 million hospital admissions and 259,000 ICU admissions (74.9% and 71.3% less, respectively, than the world without vaccinations between June and December 2021). Overall, in Italy, the model estimated over €3.0 billion costs of hospitalisations due to COVID-19 in 2020. In 2021, vaccines prevented around 36% of the overall costs.

conclusionsThis is the first study highlighting the effect of vaccines on the Italian healthcare system in terms of avoided cases, hospitalisations and costs. Our results have the potential to inform policymakers and the general population on the benefits of vaccinations.

Indexed as

COVID-19Communicable Disease ControlCOVID-19 VaccinesDelivery of Health CareHumansPandemicsSARS-CoV-2VaccinationCOVID-19 Vaccines

Identifiers

PMID35218000
PMCPMC8881093

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.